We provide end-to-end
biomanufacturing in complex modalities by integrating
cutting edge technology
We provide end-to-end
biomanufacturing in complex modalities by integrating
cutting edge technology
Innovation / Integrity / Excellence / Sustainability
Nucleic Acid
Gene Therapy
Cell Threapy
Protein Drugs
Innovation / Integrity / Excellence / Sustainability
Nucleic Acid
Gene Therapy
Cell Threapy
Protein Drugs
Vision
To establish TBMC
as the pioneer in complex biologics manufacturing.
2024
Operational Ready
2026
Validation
